Literature DB >> 28089565

FGF21 Is an Exocrine Pancreas Secretagogue.

Katie C Coate1, Genaro Hernandez1, Curtis A Thorne1, Shengyi Sun1, Thao D V Le1, Kevin Vale1, Steven A Kliewer2, David J Mangelsdorf3.   

Abstract

The metabolic stress hormone FGF21 is highly expressed in exocrine pancreas, where its levels are increased by refeeding and chemically induced pancreatitis. However, its function in the exocrine pancreas remains unknown. Here, we show that FGF21 stimulates digestive enzyme secretion from pancreatic acinar cells through an autocrine/paracrine mechanism that requires signaling through a tyrosine kinase receptor complex composed of an FGF receptor and β-Klotho. Mice lacking FGF21 accumulate zymogen granules and are susceptible to pancreatic ER stress, an effect that is reversed by administration of recombinant FGF21. Mice carrying an acinar cell-specific deletion of β-Klotho also accumulate zymogen granules but are refractory to FGF21-stimulated secretion. Like the classical post-prandial secretagogue, cholecystokinin (CCK), FGF21 triggers intracellular calcium release via PLC-IP3R signaling. However, unlike CCK, FGF21 does not induce protein synthesis, thereby preventing protein accumulation. Thus, pancreatic FGF21 is a digestive enzyme secretagogue whose physiologic function is to maintain acinar cell proteostasis.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CCK; FGF21; acinar cell; calcium signaling; exocrine pancreas; pancreatitis; proteostasis; secretagogue; secretion; β-Klotho

Mesh:

Substances:

Year:  2017        PMID: 28089565      PMCID: PMC5299054          DOI: 10.1016/j.cmet.2016.12.004

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  33 in total

1.  Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21.

Authors:  Hiroshi Kurosu; Mihwa Choi; Yasushi Ogawa; Addie S Dickson; Regina Goetz; Anna V Eliseenkova; Moosa Mohammadi; Kevin P Rosenblatt; Steven A Kliewer; Makoto Kuro-o
Journal:  J Biol Chem       Date:  2007-07-10       Impact factor: 5.157

2.  High-throughput real-time quantitative reverse transcription PCR.

Authors:  Angie L Bookout; Carolyn L Cummins; David J Mangelsdorf; Jean M Pesola; Martha F Kramer
Journal:  Curr Protoc Mol Biol       Date:  2006-02

Review 3.  Synthesis, intracellular transport and discharge of exportable proteins in the pancreatic acinar cell and other cells.

Authors:  R M Case
Journal:  Biol Rev Camb Philos Soc       Date:  1978-05

4.  CCK causes PKD1 activation in pancreatic acini by signaling through PKC-delta and PKC-independent pathways.

Authors:  Marc J Berna; K Martin Hoffmann; Jose A Tapia; Michelle Thill; Andrea Pace; Samuel A Mantey; Robert T Jensen
Journal:  Biochim Biophys Acta       Date:  2006-12-24

5.  A tyrosine-phosphorylated carboxy-terminal peptide of the fibroblast growth factor receptor (Flg) is a binding site for the SH2 domain of phospholipase C-gamma 1.

Authors:  M Mohammadi; A M Honegger; D Rotin; R Fischer; F Bellot; W Li; C A Dionne; M Jaye; M Rubinstein; J Schlessinger
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

6.  Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models--association with liver and adipose tissue effects.

Authors:  Jing Xu; Shanaka Stanislaus; Narumol Chinookoswong; Yvonne Y Lau; Todd Hager; Jennifer Patel; Hongfei Ge; Jen Weiszmann; Shu-Chen Lu; Melissa Graham; Jim Busby; Randy Hecht; Yue-Sheng Li; Yang Li; Richard Lindberg; Murielle M Véniant
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-08-25       Impact factor: 4.310

7.  Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states.

Authors:  Michael K Badman; Pavlos Pissios; Adam R Kennedy; George Koukos; Jeffrey S Flier; Eleftheria Maratos-Flier
Journal:  Cell Metab       Date:  2007-06       Impact factor: 27.287

8.  Endoplasmic reticulum stress is chronically activated in chronic pancreatitis.

Authors:  Raghuwansh P Sah; Sushil K Garg; Ajay K Dixit; Vikas Dudeja; Rajinder K Dawra; Ashok K Saluja
Journal:  J Biol Chem       Date:  2014-07-30       Impact factor: 5.157

9.  Fibroblast Growth Factor 21 (FGF21) Protects against High Fat Diet Induced Inflammation and Islet Hyperplasia in Pancreas.

Authors:  Garima Singhal; Ffolliott Martin Fisher; Melissa J Chee; Tze Guan Tan; Abdelfattah El Ouaamari; Andrew C Adams; Robert Najarian; Rohit N Kulkarni; Christophe Benoist; Jeffrey S Flier; Eleftheria Maratos-Flier
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

10.  βKlotho is required for fibroblast growth factor 21 effects on growth and metabolism.

Authors:  Xunshan Ding; Jamie Boney-Montoya; Bryn M Owen; Angie L Bookout; Katie Colbert Coate; David J Mangelsdorf; Steven A Kliewer
Journal:  Cell Metab       Date:  2012-09-05       Impact factor: 27.287

View more
  42 in total

1.  FGF21 underlies a hormetic response to metabolic stress in methylmalonic acidemia.

Authors:  Irini Manoli; Justin R Sysol; Madeline W Epping; Lina Li; Cindy Wang; Jennifer L Sloan; Alexandra Pass; Jack Gagné; Yiouli P Ktena; Lingli Li; Niraj S Trivedi; Bazoumana Ouattara; Patricia M Zerfas; Victoria Hoffmann; Mones Abu-Asab; Maria G Tsokos; David E Kleiner; Caterina Garone; Kristina Cusmano-Ozog; Gregory M Enns; Hilary J Vernon; Hans C Andersson; Stephanie Grunewald; Abdel G Elkahloun; Christiane L Girard; Jurgen Schnermann; Salvatore DiMauro; Eva Andres-Mateos; Luk H Vandenberghe; Randy J Chandler; Charles P Venditti
Journal:  JCI Insight       Date:  2018-12-06

2.  Pancreas: FGF21 gets the juices flowing.

Authors:  David Holmes
Journal:  Nat Rev Endocrinol       Date:  2017-01-30       Impact factor: 43.330

Review 3.  Fibroblast growth factor 21 in chronic kidney disease.

Authors:  Paulo Giovanni de Albuquerque Suassuna; Rogério Baumgratz de Paula; Hélady Sanders-Pinheiro; Orson W Moe; Ming-Chang Hu
Journal:  J Nephrol       Date:  2018-11-14       Impact factor: 3.902

4.  Cardiac myocyte KLF5 regulates body weight via alteration of cardiac FGF21.

Authors:  Christine J Pol; Nina M Pollak; Michael J Jurczak; Effimia Zacharia; Iordanes Karagiannides; Ioannis D Kyriazis; Panagiotis Ntziachristos; Diego A Scerbo; Brett R Brown; Iannis Aifantis; Gerald I Shulman; Ira J Goldberg; Konstantinos Drosatos
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-04-26       Impact factor: 5.187

Review 5.  The Potential Role of Fibroblast Growth Factor 21 in Lipid Metabolism and Hypertension.

Authors:  Zhe Huang; Aimin Xu; Bernard M Y Cheung
Journal:  Curr Hypertens Rep       Date:  2017-04       Impact factor: 5.369

6.  Oncogenic KRAS Reduces Expression of FGF21 in Acinar Cells to Promote Pancreatic Tumorigenesis in Mice on a High-Fat Diet.

Authors:  Yongde Luo; Yaying Yang; Muyun Liu; Dan Wang; Feng Wang; Yawei Bi; Juntao Ji; Suyun Li; Yan Liu; Rong Chen; Haojie Huang; Xiaojie Wang; Agnieszka K Swidnicka-Siergiejko; Tobias Janowitz; Semir Beyaz; Guoqiang Wang; Sulan Xu; Agnieszka B Bialkowska; Catherine K Luo; Christoph L Pin; Guang Liang; Xiongbin Lu; Maoxin Wu; Kenneth R Shroyer; Robert A Wolff; William Plunkett; Baoan Ji; Zhaoshen Li; Ellen Li; Xiaokun Li; Vincent W Yang; Craig D Logsdon; James L Abbruzzese; Weiqin Lu
Journal:  Gastroenterology       Date:  2019-07-25       Impact factor: 22.682

7.  FGF21 Is an Insulin-Dependent Postprandial Hormone in Adult Humans.

Authors:  Ricardo J Samms; Jo E Lewis; Luke Norton; Francis B Stephens; Christopher J Gaffney; Tony Butterfield; Dennis P Smith; Christine C Cheng; James W Perfield; Andrew C Adams; Francis J P Ebling; Kostas Tsintzas
Journal:  J Clin Endocrinol Metab       Date:  2017-10-01       Impact factor: 5.958

Review 8.  A Dozen Years of Discovery: Insights into the Physiology and Pharmacology of FGF21.

Authors:  Steven A Kliewer; David J Mangelsdorf
Journal:  Cell Metab       Date:  2019-02-05       Impact factor: 27.287

Review 9.  COUP-TFII revisited: Its role in metabolic gene regulation.

Authors:  Usman M Ashraf; Edwin R Sanchez; Sivarajan Kumarasamy
Journal:  Steroids       Date:  2018-11-24       Impact factor: 2.668

10.  Pancreatitis is an FGF21-deficient state that is corrected by replacement therapy.

Authors:  Genaro Hernandez; Ting Luo; Tanveer A Javed; Li Wen; Michael A Kalwat; Kevin Vale; Farah Ammouri; Sohail Z Husain; Steven A Kliewer; David J Mangelsdorf
Journal:  Sci Transl Med       Date:  2020-01-08       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.